Cart
sales@molnova.com
ON 146040
CAS No. 1404231-34-0
ON 146040 ( ZINC211117138 )
Catalog No. M26350 CAS No. 1404231-34-0
ON 146040 is an effective inhibitor of PI3K isoforms with IC50s of 14 and 20 nM for PI3Kα and PI3Kδ, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 132 | Get Quote |
|
| 5MG | 222 | Get Quote |
|
| 10MG | 357 | Get Quote |
|
| 25MG | 587 | Get Quote |
|
| 50MG | 822 | Get Quote |
|
| 100MG | 1107 | Get Quote |
|
| 500MG | 2214 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameON 146040
-
NoteResearch use only, not for human use.
-
Brief DescriptionON 146040 is an effective inhibitor of PI3K isoforms with IC50s of 14 and 20 nM for PI3Kα and PI3Kδ, respectively.
-
DescriptionON 146040 is an effective inhibitor of PI3K isoforms with IC50s of 14 and 20 nM for PI3Kα and PI3Kδ, respectively.(In Vitro):ON 146040 inhibits Abl1 and several mutant versions of this kinase with IC50SynonymsZINC211117138PathwayPI3K/Akt/mTOR signalingTargetPI3KRecptorCB1Research Area——Indication——
Chemical Information
-
CAS Number1404231-34-0
-
Formula Weight489.6
-
Molecular FormulaC24H23N7O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN1CCN(CC1)c1ccc(Nc2ncc3NC(=O)\C(Sc3n2)=C\c2ccc(cc2)[N+]([O-])=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Molecular analysis of genetic fidelity in Cannabis sativa L. plants grown from synthetic (encapsulated) seeds following in vitro storage. Biotechnology Letters, 2011, 33(12):2503-2508.
molnova catalog
related products
-
NVP-BKM120 hydrochlo...
A potent, selective, orally bioavailable inhibitor of class I PI3K isoforms.
-
PQR309
PQR309 (Bimiralisib) is a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor with IC50 of 33, 451, 661, 708 and 89 nM for PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ and mTOR, respectively.
-
MOMIPP
MOMIPP is a PIKfyve inhibitor and a macropinocytosis inducer. MOMIPP readily penetrates the blood-brain barrier and is moderately effective in suppressing progression of intracerebral glioblastoma xenografts.
